

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.88112534 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.88112534 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.88112534 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.88112534 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.88112534 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.88112534 |
| 7 | piRNA metabolic process (GO:0034587) | 5.52586188 |
| 8 | phagocytosis, recognition (GO:0006910) | 5.27174623 |
| 9 | regulation of meiosis I (GO:0060631) | 4.80086360 |
| 10 | glycosphingolipid catabolic process (GO:0046479) | 4.56902821 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 4.52345233 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.48972089 |
| 13 | glycolipid catabolic process (GO:0019377) | 4.29617559 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.08068021 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.02221433 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.01741708 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 3.97709571 |
| 18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.96963919 |
| 19 | synaptonemal complex assembly (GO:0007130) | 3.93889870 |
| 20 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.92835592 |
| 21 | natural killer cell mediated immunity (GO:0002228) | 3.92835592 |
| 22 | microglial cell activation (GO:0001774) | 3.86708926 |
| 23 | DNA methylation involved in gamete generation (GO:0043046) | 3.79708046 |
| 24 | cellular extravasation (GO:0045123) | 3.73006173 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.69614599 |
| 26 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.61373401 |
| 27 | cellular response to arsenic-containing substance (GO:0071243) | 3.59153169 |
| 28 | low-density lipoprotein particle clearance (GO:0034383) | 3.57191368 |
| 29 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.54619884 |
| 30 | ceramide catabolic process (GO:0046514) | 3.52063705 |
| 31 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.50084497 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.48500750 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42988102 |
| 34 | response to host immune response (GO:0052572) | 3.42988102 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.42534783 |
| 36 | response to peptidoglycan (GO:0032494) | 3.42238556 |
| 37 | synaptonemal complex organization (GO:0070193) | 3.41894655 |
| 38 | positive regulation of extracellular matrix organization (GO:1903055) | 3.40348775 |
| 39 | macrophage activation (GO:0042116) | 3.37144640 |
| 40 | meiotic chromosome segregation (GO:0045132) | 3.37140058 |
| 41 | macroautophagy (GO:0016236) | 3.36153726 |
| 42 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.35548254 |
| 43 | I-kappaB phosphorylation (GO:0007252) | 3.35407650 |
| 44 | nuclear pore complex assembly (GO:0051292) | 3.33583622 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.27181511 |
| 46 | male meiosis (GO:0007140) | 3.26396207 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.24374821 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 3.22567958 |
| 49 | response to host (GO:0075136) | 3.21286252 |
| 50 | response to host defenses (GO:0052200) | 3.21286252 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21286252 |
| 52 | pinocytosis (GO:0006907) | 3.20127816 |
| 53 | germinal center formation (GO:0002467) | 3.19472929 |
| 54 | negative regulation of meiosis (GO:0045835) | 3.19081282 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.18301123 |
| 56 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.17104199 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.15796512 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13805482 |
| 59 | positive regulation of interferon-beta production (GO:0032728) | 3.10232043 |
| 60 | positive regulation of leukocyte degranulation (GO:0043302) | 3.06583487 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.02752537 |
| 62 | response to laminar fluid shear stress (GO:0034616) | 3.02556767 |
| 63 | regulation of vitamin metabolic process (GO:0030656) | 3.01062327 |
| 64 | membrane raft organization (GO:0031579) | 3.00760385 |
| 65 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.98743815 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98399243 |
| 67 | DNA synthesis involved in DNA repair (GO:0000731) | 2.97930994 |
| 68 | osteoclast differentiation (GO:0030316) | 2.96929515 |
| 69 | pore complex assembly (GO:0046931) | 2.95604966 |
| 70 | protein localization to endosome (GO:0036010) | 2.95556162 |
| 71 | response to muramyl dipeptide (GO:0032495) | 2.92888935 |
| 72 | nuclear pore organization (GO:0006999) | 2.91239210 |
| 73 | response to UV-C (GO:0010225) | 2.88769218 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.88106033 |
| 75 | histone H3-K9 methylation (GO:0051567) | 2.87707266 |
| 76 | negative regulation of lipid storage (GO:0010888) | 2.87226277 |
| 77 | cellular response to ethanol (GO:0071361) | 2.87126054 |
| 78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84430174 |
| 79 | negative regulation of granulocyte differentiation (GO:0030853) | 2.82973520 |
| 80 | germ cell migration (GO:0008354) | 2.82925272 |
| 81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.80743293 |
| 82 | T-helper 1 type immune response (GO:0042088) | 2.78634702 |
| 83 | oogenesis (GO:0048477) | 2.77982855 |
| 84 | iron ion import (GO:0097286) | 2.77510700 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76232014 |
| 86 | membrane lipid catabolic process (GO:0046466) | 2.75596542 |
| 87 | negative regulation of fibrinolysis (GO:0051918) | 2.75294763 |
| 88 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.74782618 |
| 89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.72002718 |
| 90 | granulocyte activation (GO:0036230) | 2.70842854 |
| 91 | regulation of protein polyubiquitination (GO:1902914) | 2.69613553 |
| 92 | negative regulation of mast cell activation (GO:0033004) | 2.68221176 |
| 93 | positive regulation of mast cell activation (GO:0033005) | 2.66983792 |
| 94 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.66869120 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66326275 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.65896035 |
| 97 | positive regulation of cholesterol efflux (GO:0010875) | 2.65780115 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 2.64617273 |
| 99 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64606568 |
| 100 | regulation of monocyte differentiation (GO:0045655) | 2.63970016 |
| 101 | regulation of mast cell activation (GO:0033003) | 2.62896519 |
| 102 | regulation of DNA endoreduplication (GO:0032875) | 2.62311379 |
| 103 | macrophage differentiation (GO:0030225) | 2.62007825 |
| 104 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61981622 |
| 105 | detection of external biotic stimulus (GO:0098581) | 2.61792663 |
| 106 | respiratory burst (GO:0045730) | 2.61481833 |
| 107 | apoptotic cell clearance (GO:0043277) | 2.60337052 |
| 108 | positive regulation of mast cell degranulation (GO:0043306) | 2.59387287 |
| 109 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59387287 |
| 110 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59107988 |
| 111 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.58656376 |
| 112 | male meiosis I (GO:0007141) | 2.58075326 |
| 113 | sphingolipid catabolic process (GO:0030149) | 2.56857611 |
| 114 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.56166637 |
| 115 | chromosome organization involved in meiosis (GO:0070192) | 2.56103725 |
| 116 | mRNA transcription (GO:0009299) | 2.55154702 |
| 117 | regulation of superoxide anion generation (GO:0032928) | 2.55059213 |
| 118 | mitotic chromosome condensation (GO:0007076) | 2.54860519 |
| 119 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54654899 |
| 120 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.54630680 |
| 121 | myeloid dendritic cell differentiation (GO:0043011) | 2.54500063 |
| 122 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.53833693 |
| 123 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.53363784 |
| 124 | meiotic nuclear division (GO:0007126) | 2.52360048 |
| 125 | histone H3-K9 modification (GO:0061647) | 2.51963936 |
| 126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51663117 |
| 127 | leukocyte mediated cytotoxicity (GO:0001909) | 2.51653189 |
| 128 | detection of other organism (GO:0098543) | 2.51315271 |
| 129 | regulation of macrophage chemotaxis (GO:0010758) | 2.50627600 |
| 130 | regulation of interferon-beta production (GO:0032648) | 2.49805824 |
| 131 | mitotic sister chromatid cohesion (GO:0007064) | 2.49075063 |
| 132 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.48976074 |
| 133 | regulation of mononuclear cell migration (GO:0071675) | 2.48749195 |
| 134 | regulation of integrin activation (GO:0033623) | 2.48698224 |
| 135 | detection of biotic stimulus (GO:0009595) | 2.48167050 |
| 136 | mannose metabolic process (GO:0006013) | 2.46966675 |
| 137 | regulation of cholesterol homeostasis (GO:2000188) | 2.46248680 |
| 138 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.45829168 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.45359126 |
| 140 | cellular response to lipopolysaccharide (GO:0071222) | 2.44721740 |
| 141 | positive regulation of male gonad development (GO:2000020) | 2.44213357 |
| 142 | embryonic process involved in female pregnancy (GO:0060136) | 2.44065938 |
| 143 | acute-phase response (GO:0006953) | 2.43422581 |
| 144 | establishment of endothelial barrier (GO:0061028) | 2.43369098 |
| 145 | positive regulation of p38MAPK cascade (GO:1900745) | 2.42838696 |
| 146 | regulation of mast cell degranulation (GO:0043304) | 2.42201133 |
| 147 | N-acetylneuraminate metabolic process (GO:0006054) | 2.41494888 |
| 148 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.41244913 |
| 149 | negative regulation of cell killing (GO:0031342) | 2.41244913 |
| 150 | cellular response to molecule of bacterial origin (GO:0071219) | 2.40922681 |
| 151 | negative regulation of interleukin-8 production (GO:0032717) | 2.40557720 |
| 152 | gene silencing by RNA (GO:0031047) | 2.40332330 |
| 153 | sister chromatid cohesion (GO:0007062) | 2.39501972 |
| 154 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.39400734 |
| 155 | lipopolysaccharide metabolic process (GO:0008653) | 2.38789302 |
| 156 | regulation of leukocyte degranulation (GO:0043300) | 2.38011099 |
| 157 | response to lipoprotein particle (GO:0055094) | 2.37483997 |
| 158 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.36883302 |
| 159 | protein-lipid complex assembly (GO:0065005) | 2.36741825 |
| 160 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.36731522 |
| 161 | response to thyroid hormone (GO:0097066) | 2.36505367 |
| 162 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.36425718 |
| 163 | DNA methylation (GO:0006306) | 2.36210282 |
| 164 | DNA alkylation (GO:0006305) | 2.36210282 |
| 165 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.36151752 |
| 166 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.35881658 |
| 167 | complement activation, alternative pathway (GO:0006957) | 2.35749218 |
| 168 | regulation of cholesterol storage (GO:0010885) | 2.35263399 |
| 169 | myeloid leukocyte mediated immunity (GO:0002444) | 2.35032065 |
| 170 | regulation of response to interferon-gamma (GO:0060330) | 2.34193020 |
| 171 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.34096703 |
| 172 | positive regulation of heat generation (GO:0031652) | 2.33936135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.21755233 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.64676491 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.20748778 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.94892209 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.94867787 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.88500003 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.87023934 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63149256 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.50835731 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.41755289 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35038094 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97394141 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75726666 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52125824 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.51503399 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44334753 |
| 17 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.40373600 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.35740355 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.29550080 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11826412 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.10448961 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.06889035 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02717213 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02177333 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99072116 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91467839 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.90759160 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89797165 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88597004 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87391300 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.86592351 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84392173 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80962891 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80415870 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79473664 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.78252863 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.77518881 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76027006 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.73218849 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71898115 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67510225 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66741233 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.66738195 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65790314 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64271701 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63450971 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60275637 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.55886840 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53485835 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48512979 |
| 51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.48296434 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46582333 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46467305 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45796191 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45775414 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44808681 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43325447 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42413108 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.40352515 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39716283 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.38417162 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.37658461 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37627754 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35472387 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33522811 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31405061 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30778945 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29826018 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26886936 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26423276 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25216319 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23596692 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22007236 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21840704 |
| 75 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21679531 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20246926 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19349471 |
| 78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17453979 |
| 79 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17072089 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16475472 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15585831 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15150279 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14694315 |
| 84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13857450 |
| 85 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13266062 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12699367 |
| 87 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.12434701 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12165003 |
| 89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12082139 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12082139 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11856620 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11818575 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11294322 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10008652 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09963271 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09848071 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08142938 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07368939 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07207895 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06228744 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05623311 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04860200 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04277158 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03206853 |
| 105 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02933309 |
| 106 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01637873 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01326034 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01245881 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00985308 |
| 110 | MYC_22102868_ChIP-Seq_BL_Human | 1.00784683 |
| 111 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99862957 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97610504 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96106616 |
| 114 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95351574 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94336155 |
| 116 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94315942 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93250380 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89720816 |
| 119 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.89574907 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87501949 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.86151937 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85628269 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85503106 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81279165 |
| 125 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81113970 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80737886 |
| 127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80698776 |
| 128 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80672837 |
| 129 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80500586 |
| 130 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.80422868 |
| 131 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79336885 |
| 132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79165624 |
| 133 | MAF_26560356_Chip-Seq_TH2_Human | 0.79100566 |
| 134 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.78892950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.80672616 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.47505019 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.37187665 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.11484915 |
| 5 | MP0005451_abnormal_body_composition | 3.08347952 |
| 6 | MP0008877_abnormal_DNA_methylation | 3.03230523 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.70650102 |
| 8 | MP0009278_abnormal_bone_marrow | 2.58719815 |
| 9 | MP0002419_abnormal_innate_immunity | 2.53821930 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.52916120 |
| 11 | MP0010307_abnormal_tumor_latency | 2.51507899 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.49596937 |
| 13 | MP0006082_CNS_inflammation | 2.27849494 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.23857645 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.22945343 |
| 16 | MP0003436_decreased_susceptibility_to | 2.16937910 |
| 17 | MP0003303_peritoneal_inflammation | 2.06992601 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.06005537 |
| 19 | MP0000371_diluted_coat_color | 1.90892766 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.90289041 |
| 21 | MP0002396_abnormal_hematopoietic_system | 1.87363522 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.87088047 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.82224410 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.82224410 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.81990991 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.74181513 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.72705713 |
| 28 | MP0003075_altered_response_to | 1.68227497 |
| 29 | MP0002723_abnormal_immune_serum | 1.64830122 |
| 30 | MP0005025_abnormal_response_to | 1.64435169 |
| 31 | MP0004510_myositis | 1.64247525 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.64235755 |
| 33 | MP0008995_early_reproductive_senescence | 1.64177088 |
| 34 | MP0001853_heart_inflammation | 1.61694662 |
| 35 | MP0009840_abnormal_foam_cell | 1.59901709 |
| 36 | MP0001819_abnormal_immune_cell | 1.57390522 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.56709274 |
| 38 | MP0001800_abnormal_humoral_immune | 1.56051723 |
| 39 | MP0003448_altered_tumor_morphology | 1.55896257 |
| 40 | MP0010094_abnormal_chromosome_stability | 1.52406269 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.47635311 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.47421688 |
| 43 | MP0003111_abnormal_nucleus_morphology | 1.44791884 |
| 44 | MP0004947_skin_inflammation | 1.42909794 |
| 45 | MP0005365_abnormal_bile_salt | 1.42688666 |
| 46 | MP0003690_abnormal_glial_cell | 1.40460978 |
| 47 | MP0009785_altered_susceptibility_to | 1.39543065 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.38410880 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.35860312 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.34154843 |
| 51 | MP0004233_abnormal_muscle_weight | 1.31624309 |
| 52 | MP0005164_abnormal_response_to | 1.31538505 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.26085790 |
| 54 | MP0003077_abnormal_cell_cycle | 1.23461915 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.23069518 |
| 56 | MP0005671_abnormal_response_to | 1.22116105 |
| 57 | MP0001851_eye_inflammation | 1.20655891 |
| 58 | MP0002398_abnormal_bone_marrow | 1.20434781 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.18591497 |
| 60 | MP0002210_abnormal_sex_determination | 1.17855648 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.17456355 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.14761208 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.13876335 |
| 64 | MP0003646_muscle_fatigue | 1.13599211 |
| 65 | MP0000716_abnormal_immune_system | 1.13484038 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.12428396 |
| 67 | MP0004185_abnormal_adipocyte_glucose | 1.11795744 |
| 68 | MP0003724_increased_susceptibility_to | 1.11389597 |
| 69 | MP0003693_abnormal_embryo_hatching | 1.11384307 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.11212257 |
| 71 | MP0000685_abnormal_immune_system | 1.10973584 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.10862694 |
| 73 | MP0002405_respiratory_system_inflammati | 1.10234869 |
| 74 | MP0001790_abnormal_immune_system | 1.09486535 |
| 75 | MP0005387_immune_system_phenotype | 1.09486535 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08510806 |
| 77 | MP0001929_abnormal_gametogenesis | 1.08338471 |
| 78 | MP0003091_abnormal_cell_migration | 1.08074196 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.07813736 |
| 80 | MP0000609_abnormal_liver_physiology | 1.06621252 |
| 81 | MP0005310_abnormal_salivary_gland | 1.04355842 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.04218118 |
| 83 | MP0003878_abnormal_ear_physiology | 1.02562680 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 1.02562680 |
| 85 | MP0002722_abnormal_immune_system | 1.02508508 |
| 86 | MP0001915_intracranial_hemorrhage | 1.01444975 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 1.00438419 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.00037978 |
| 89 | MP0002429_abnormal_blood_cell | 0.99773636 |
| 90 | MP0005408_hypopigmentation | 0.99161371 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.98997863 |
| 92 | MP0003329_amyloid_beta_deposits | 0.98272601 |
| 93 | MP0001145_abnormal_male_reproductive | 0.97978169 |
| 94 | MP0002006_tumorigenesis | 0.97308184 |
| 95 | MP0003828_pulmonary_edema | 0.97255467 |
| 96 | MP0008469_abnormal_protein_level | 0.94909570 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.94903456 |
| 98 | MP0009764_decreased_sensitivity_to | 0.93769220 |
| 99 | MP0001958_emphysema | 0.92911258 |
| 100 | MP0008057_abnormal_DNA_replication | 0.92199705 |
| 101 | MP0005171_absent_coat_pigmentation | 0.92176285 |
| 102 | MP0000343_altered_response_to | 0.90793903 |
| 103 | MP0002075_abnormal_coat/hair_pigmentati | 0.90501922 |
| 104 | MP0005166_decreased_susceptibility_to | 0.89723319 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.89278107 |
| 106 | MP0003786_premature_aging | 0.88501619 |
| 107 | MP0005165_increased_susceptibility_to | 0.88469193 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.87804770 |
| 109 | MP0000747_muscle_weakness | 0.87679008 |
| 110 | MP0008260_abnormal_autophagy | 0.87604735 |
| 111 | MP0000604_amyloidosis | 0.87349918 |
| 112 | MP0002009_preneoplasia | 0.87315721 |
| 113 | MP0000653_abnormal_sex_gland | 0.87089670 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.85895042 |
| 115 | MP0008004_abnormal_stomach_pH | 0.85825840 |
| 116 | MP0005621_abnormal_cell_physiology | 0.85667170 |
| 117 | MP0009763_increased_sensitivity_to | 0.85249602 |
| 118 | MP0009115_abnormal_fat_cell | 0.85086760 |
| 119 | MP0009697_abnormal_copulation | 0.84870739 |
| 120 | MP0003195_calcinosis | 0.84459501 |
| 121 | MP0005647_abnormal_sex_gland | 0.82331125 |
| 122 | MP0000383_abnormal_hair_follicle | 0.81845600 |
| 123 | MP0001727_abnormal_embryo_implantation | 0.81833941 |
| 124 | MP0002971_abnormal_brown_adipose | 0.80931748 |
| 125 | MP0004130_abnormal_muscle_cell | 0.78941048 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.78612283 |
| 127 | MP0000858_altered_metastatic_potential | 0.77405936 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.76340091 |
| 129 | MP0000749_muscle_degeneration | 0.75383364 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.75338880 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.74835713 |
| 132 | MP0005023_abnormal_wound_healing | 0.74776936 |
| 133 | MP0004883_abnormal_blood_vessel | 0.74385710 |
| 134 | MP0001873_stomach_inflammation | 0.73823748 |
| 135 | MP0005334_abnormal_fat_pad | 0.73186968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.52072039 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.50666929 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.09819164 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.02413314 |
| 5 | Prostate neoplasm (HP:0100787) | 3.92659162 |
| 6 | Upper motor neuron abnormality (HP:0002127) | 3.80514239 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75481281 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.52473071 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.28719795 |
| 10 | Absent frontal sinuses (HP:0002688) | 3.26413762 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.25964967 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.25699874 |
| 13 | Increased serum ferritin (HP:0003281) | 3.14588199 |
| 14 | Amyloidosis (HP:0011034) | 3.10187408 |
| 15 | Spondylolisthesis (HP:0003302) | 3.06880577 |
| 16 | Myositis (HP:0100614) | 2.98835548 |
| 17 | Recurrent skin infections (HP:0001581) | 2.98364926 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 2.97460549 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 2.97329646 |
| 20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.94017943 |
| 21 | Gingivitis (HP:0000230) | 2.92959271 |
| 22 | Abnormality of the fingertips (HP:0001211) | 2.87923596 |
| 23 | Orchitis (HP:0100796) | 2.87856700 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 2.86743304 |
| 25 | Hematochezia (HP:0002573) | 2.84217154 |
| 26 | Chromsome breakage (HP:0040012) | 2.83772000 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.81781669 |
| 28 | Myocardial infarction (HP:0001658) | 2.79751897 |
| 29 | Exercise-induced myalgia (HP:0003738) | 2.79286925 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77858415 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77858415 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77858415 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.76946593 |
| 34 | Optic neuritis (HP:0100653) | 2.76946593 |
| 35 | Periodontitis (HP:0000704) | 2.75079660 |
| 36 | Syringomyelia (HP:0003396) | 2.73001806 |
| 37 | Spinal cord lesions (HP:0100561) | 2.73001806 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72394914 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72394914 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72394914 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.69852791 |
| 42 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68075789 |
| 43 | Disinhibition (HP:0000734) | 2.65932412 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.65759372 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65759372 |
| 46 | Complement deficiency (HP:0004431) | 2.64447287 |
| 47 | Azoospermia (HP:0000027) | 2.62966749 |
| 48 | Fatigue (HP:0012378) | 2.62917590 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.61283158 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60910987 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60910987 |
| 52 | Conjunctival telangiectasia (HP:0000524) | 2.60525542 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.59439884 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.59439884 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.58620949 |
| 56 | Abnormal platelet function (HP:0011869) | 2.55066485 |
| 57 | Impaired platelet aggregation (HP:0003540) | 2.55066485 |
| 58 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.53010891 |
| 59 | Male infertility (HP:0003251) | 2.48652689 |
| 60 | J-shaped sella turcica (HP:0002680) | 2.48332640 |
| 61 | Albinism (HP:0001022) | 2.48103005 |
| 62 | Abnormality of complement system (HP:0005339) | 2.48016288 |
| 63 | Skin nodule (HP:0200036) | 2.44510770 |
| 64 | Abnormality of iron homeostasis (HP:0011031) | 2.43085973 |
| 65 | Abnormality of the periventricular white matter (HP:0002518) | 2.43046616 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.42763265 |
| 67 | Xanthomatosis (HP:0000991) | 2.41505598 |
| 68 | Thick nail (HP:0001805) | 2.40189591 |
| 69 | Agnosia (HP:0010524) | 2.40159291 |
| 70 | Spinal muscular atrophy (HP:0007269) | 2.38552994 |
| 71 | Gingival bleeding (HP:0000225) | 2.36016175 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.32690938 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32003699 |
| 74 | Thrombocytosis (HP:0001894) | 2.31074599 |
| 75 | Pustule (HP:0200039) | 2.30516403 |
| 76 | Purpura (HP:0000979) | 2.29733675 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.28875126 |
| 78 | Abnormal spermatogenesis (HP:0008669) | 2.28642658 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.28234932 |
| 80 | Loss of speech (HP:0002371) | 2.24612373 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22877539 |
| 82 | Neurodegeneration (HP:0002180) | 2.22331599 |
| 83 | Abnormality of the frontal sinuses (HP:0002687) | 2.22310714 |
| 84 | Arterial thrombosis (HP:0004420) | 2.21196058 |
| 85 | Stomatitis (HP:0010280) | 2.20805614 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.16510886 |
| 87 | Ectopic kidney (HP:0000086) | 2.16306482 |
| 88 | Vertebral compression fractures (HP:0002953) | 2.15382248 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.15220552 |
| 90 | Osteomyelitis (HP:0002754) | 2.14745728 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14018307 |
| 92 | Obstructive lung disease (HP:0006536) | 2.14018307 |
| 93 | Hand muscle atrophy (HP:0009130) | 2.10149299 |
| 94 | Tetraparesis (HP:0002273) | 2.09939431 |
| 95 | Axonal loss (HP:0003447) | 2.07453162 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.07282531 |
| 97 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.04587809 |
| 98 | Nuclear cataract (HP:0100018) | 2.04090089 |
| 99 | Polycythemia (HP:0001901) | 2.03876105 |
| 100 | Recurrent viral infections (HP:0004429) | 2.01936248 |
| 101 | Neuronal loss in central nervous system (HP:0002529) | 2.01507287 |
| 102 | Deformed sella turcica (HP:0002681) | 2.00819807 |
| 103 | Abnormality of male internal genitalia (HP:0000022) | 2.00250012 |
| 104 | Urethral obstruction (HP:0000796) | 1.99784790 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.98424517 |
| 106 | Acute myeloid leukemia (HP:0004808) | 1.98400041 |
| 107 | Hypoalphalipoproteinemia (HP:0003233) | 1.97959963 |
| 108 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97893450 |
| 109 | Hypercholesterolemia (HP:0003124) | 1.97021119 |
| 110 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94319902 |
| 111 | Pulmonary infiltrates (HP:0002113) | 1.93557391 |
| 112 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92934553 |
| 113 | Subaortic stenosis (HP:0001682) | 1.92934553 |
| 114 | Increased connective tissue (HP:0009025) | 1.92308987 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91751454 |
| 116 | Nausea (HP:0002018) | 1.90687918 |
| 117 | Epistaxis (HP:0000421) | 1.90167572 |
| 118 | Bone pain (HP:0002653) | 1.89605989 |
| 119 | Myelodysplasia (HP:0002863) | 1.88623555 |
| 120 | Persistence of primary teeth (HP:0006335) | 1.88430257 |
| 121 | Clubbing of toes (HP:0100760) | 1.88302113 |
| 122 | Vasculitis (HP:0002633) | 1.87642556 |
| 123 | Abnormality of the thoracic spine (HP:0100711) | 1.87401370 |
| 124 | Generalized hypopigmentation (HP:0007513) | 1.86610426 |
| 125 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86273763 |
| 126 | Hemorrhage of the eye (HP:0011885) | 1.85090666 |
| 127 | Peripheral demyelination (HP:0011096) | 1.83777989 |
| 128 | Leukocytosis (HP:0001974) | 1.83395911 |
| 129 | Ocular albinism (HP:0001107) | 1.83053498 |
| 130 | Thoracic kyphosis (HP:0002942) | 1.82773660 |
| 131 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82353160 |
| 132 | Prolonged bleeding time (HP:0003010) | 1.82101511 |
| 133 | Slow saccadic eye movements (HP:0000514) | 1.81648476 |
| 134 | Nephritis (HP:0000123) | 1.81138406 |
| 135 | Glomerulonephritis (HP:0000099) | 1.80696546 |
| 136 | Polyneuropathy (HP:0001271) | 1.79727651 |
| 137 | Apathy (HP:0000741) | 1.78584635 |
| 138 | Hypertriglyceridemia (HP:0002155) | 1.77830356 |
| 139 | Joint hemorrhage (HP:0005261) | 1.77419492 |
| 140 | Gonadotropin excess (HP:0000837) | 1.77369368 |
| 141 | Hypolipoproteinemia (HP:0010981) | 1.76109093 |
| 142 | Keratoconjunctivitis sicca (HP:0001097) | 1.75714483 |
| 143 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75030674 |
| 144 | Increased CSF protein (HP:0002922) | 1.74476784 |
| 145 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73244849 |
| 146 | Ragged-red muscle fibers (HP:0003200) | 1.72645544 |
| 147 | Pathologic fracture (HP:0002756) | 1.72577570 |
| 148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71600408 |
| 149 | Abnormality of the Achilles tendon (HP:0005109) | 1.70148612 |
| 150 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.69417109 |
| 151 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.69260010 |
| 152 | Petechiae (HP:0000967) | 1.68359987 |
| 153 | Diminished motivation (HP:0000745) | 1.67862671 |
| 154 | Mutism (HP:0002300) | 1.66255768 |
| 155 | Retinal atrophy (HP:0001105) | 1.66239602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 4.98836814 |
| 2 | BRD4 | 3.04162752 |
| 3 | KIT | 3.03355450 |
| 4 | PDK2 | 2.82400616 |
| 5 | PRPF4B | 2.79889759 |
| 6 | IRAK4 | 2.69622628 |
| 7 | IRAK3 | 2.59920330 |
| 8 | NME2 | 2.55160637 |
| 9 | BLK | 2.39653870 |
| 10 | MST1R | 2.36969564 |
| 11 | TYK2 | 2.32499085 |
| 12 | RIPK4 | 2.31447770 |
| 13 | CAMK1D | 2.26166215 |
| 14 | MAP3K14 | 2.14257754 |
| 15 | TAOK3 | 2.14138761 |
| 16 | TAOK2 | 2.11297748 |
| 17 | LATS1 | 1.98629011 |
| 18 | TIE1 | 1.96415057 |
| 19 | GRK7 | 1.94512180 |
| 20 | MOS | 1.92568304 |
| 21 | TBK1 | 1.88830084 |
| 22 | ICK | 1.88271616 |
| 23 | NEK2 | 1.70704952 |
| 24 | JAK3 | 1.68639630 |
| 25 | RIPK1 | 1.67019646 |
| 26 | BMX | 1.65639860 |
| 27 | CDK9 | 1.65342431 |
| 28 | MAP2K3 | 1.60513857 |
| 29 | RPS6KA4 | 1.58059696 |
| 30 | MAP3K6 | 1.54007861 |
| 31 | BMPR2 | 1.50824968 |
| 32 | TEC | 1.46438545 |
| 33 | CAMK1G | 1.45306640 |
| 34 | STK3 | 1.43436725 |
| 35 | IKBKB | 1.41280903 |
| 36 | CHUK | 1.38158129 |
| 37 | NEK9 | 1.38090352 |
| 38 | MAP3K1 | 1.37863797 |
| 39 | CDC7 | 1.36687556 |
| 40 | FES | 1.28007125 |
| 41 | CDK6 | 1.24669991 |
| 42 | IKBKE | 1.24299864 |
| 43 | IRAK2 | 1.22047172 |
| 44 | NUAK1 | 1.21893802 |
| 45 | MAP4K1 | 1.21245836 |
| 46 | TGFBR2 | 1.15696896 |
| 47 | MAP3K2 | 1.13693664 |
| 48 | MAP3K13 | 1.13685865 |
| 49 | IRAK1 | 1.12469572 |
| 50 | PTK6 | 1.11418274 |
| 51 | KSR2 | 1.10345733 |
| 52 | MAP3K3 | 1.10133327 |
| 53 | CSF1R | 1.06833921 |
| 54 | HCK | 1.05875471 |
| 55 | MATK | 1.03808530 |
| 56 | PLK4 | 1.03664976 |
| 57 | CDK4 | 1.02117900 |
| 58 | ATR | 1.00851102 |
| 59 | STK4 | 1.00121574 |
| 60 | TAOK1 | 0.98457968 |
| 61 | PDPK1 | 0.97825085 |
| 62 | FGR | 0.97687340 |
| 63 | TTN | 0.96191927 |
| 64 | PIM2 | 0.95550487 |
| 65 | RPS6KA2 | 0.92567378 |
| 66 | STK10 | 0.90666848 |
| 67 | MKNK2 | 0.89005809 |
| 68 | MAP3K11 | 0.88631120 |
| 69 | DDR2 | 0.87505957 |
| 70 | PIM1 | 0.86117392 |
| 71 | MAPK12 | 0.85124157 |
| 72 | MARK3 | 0.84666898 |
| 73 | SGK2 | 0.84267797 |
| 74 | ZAP70 | 0.83074310 |
| 75 | WEE1 | 0.81014927 |
| 76 | ZAK | 0.80899123 |
| 77 | BTK | 0.80519612 |
| 78 | JAK1 | 0.80475077 |
| 79 | MTOR | 0.78589889 |
| 80 | SGK3 | 0.78417506 |
| 81 | TXK | 0.78143415 |
| 82 | CDK7 | 0.77065402 |
| 83 | PDK1 | 0.76291861 |
| 84 | CDC42BPA | 0.76201244 |
| 85 | EGFR | 0.75938292 |
| 86 | TRPM7 | 0.74035594 |
| 87 | PIK3CG | 0.73706001 |
| 88 | PLK1 | 0.71525859 |
| 89 | TSSK6 | 0.71091250 |
| 90 | EPHB1 | 0.68868039 |
| 91 | ATM | 0.67504993 |
| 92 | ERN1 | 0.67319621 |
| 93 | LATS2 | 0.67297171 |
| 94 | PAK4 | 0.66271844 |
| 95 | TRIB3 | 0.64469130 |
| 96 | MELK | 0.63316925 |
| 97 | LCK | 0.63125681 |
| 98 | PKN2 | 0.62583951 |
| 99 | CLK1 | 0.62436162 |
| 100 | MAP3K8 | 0.61879068 |
| 101 | EPHA2 | 0.61556524 |
| 102 | ERBB4 | 0.61316350 |
| 103 | ALK | 0.60642660 |
| 104 | SIK2 | 0.60465989 |
| 105 | RPS6KA6 | 0.60364177 |
| 106 | CDK8 | 0.59307533 |
| 107 | SIK3 | 0.58482095 |
| 108 | MAPK7 | 0.56991583 |
| 109 | ARAF | 0.56726143 |
| 110 | JAK2 | 0.56536271 |
| 111 | CSK | 0.55405069 |
| 112 | EPHA3 | 0.55088962 |
| 113 | PRKAA2 | 0.54707097 |
| 114 | LYN | 0.54422730 |
| 115 | ABL1 | 0.54353681 |
| 116 | ABL2 | 0.53480562 |
| 117 | CAMKK2 | 0.53479687 |
| 118 | EEF2K | 0.52324432 |
| 119 | RPS6KC1 | 0.52181622 |
| 120 | RPS6KL1 | 0.52181622 |
| 121 | OBSCN | 0.52101670 |
| 122 | RAF1 | 0.51219380 |
| 123 | SCYL2 | 0.50554312 |
| 124 | FGFR4 | 0.50526462 |
| 125 | AURKB | 0.49161966 |
| 126 | MARK2 | 0.47556406 |
| 127 | MAP3K7 | 0.46681066 |
| 128 | TTK | 0.46664118 |
| 129 | ACVR1B | 0.46606900 |
| 130 | SYK | 0.46191457 |
| 131 | SIK1 | 0.45666704 |
| 132 | GSK3A | 0.44295107 |
| 133 | FGFR3 | 0.44062996 |
| 134 | RPS6KA5 | 0.42097934 |
| 135 | TESK2 | 0.41553612 |
| 136 | MAPK4 | 0.41110935 |
| 137 | MKNK1 | 0.41075907 |
| 138 | KSR1 | 0.38910267 |
| 139 | MAPK11 | 0.38396328 |
| 140 | MAPK1 | 0.38206195 |
| 141 | DAPK2 | 0.38075265 |
| 142 | CHEK1 | 0.38061397 |
| 143 | PRKD3 | 0.36299574 |
| 144 | CDK2 | 0.36244958 |
| 145 | PDGFRB | 0.35626179 |
| 146 | MAP3K5 | 0.34080364 |
| 147 | BRSK2 | 0.32654040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.57077632 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56425703 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.20238452 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19281712 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18305935 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15645695 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.05905379 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01516937 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 1.83747752 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75052745 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72039346 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 1.66351539 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58227337 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57452745 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.55308912 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54575397 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.53596442 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.52566537 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49012229 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47622179 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43648562 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39948069 |
| 23 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.39525340 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.38083138 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.36297076 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33733819 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.32388111 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30277591 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.29779061 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.28209213 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27458394 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25445903 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24893933 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23240361 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20562124 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.16920135 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15813156 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14886917 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13133675 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11846750 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.11447571 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09442609 |
| 43 | Cell cycle_Homo sapiens_hsa04110 | 1.08548453 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07339048 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07249592 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.05958723 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04377679 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00840709 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00568924 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99465304 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97052957 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96596351 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95671381 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95370329 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91262149 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90019953 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.88374981 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.88040890 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84052702 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83659360 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83458014 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82967444 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81695874 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.81558657 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81141000 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81114828 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79726448 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77157884 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77094124 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76916316 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76673041 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75927563 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74476288 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74179328 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73331903 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71619046 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71068190 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71055011 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70502072 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70018377 |
| 81 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69874161 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68898974 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.67384530 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66694455 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66285547 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.66267796 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.65838629 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.65215369 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65194481 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64987275 |
| 91 | DNA replication_Homo sapiens_hsa03030 | 0.64514761 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64428059 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63783682 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62483641 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61514631 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60132526 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.59708125 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.59242983 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57972641 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56099890 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55213105 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.54580720 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53588392 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52571562 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52334351 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52227596 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52000778 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51511800 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51468561 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51293817 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51202294 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51051697 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50623277 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.50022632 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47582829 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46351310 |
| 117 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45732134 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45492419 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44225642 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43977632 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43891859 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42405806 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40627492 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40093691 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39285630 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39118443 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34797221 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33434051 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32980604 |

